CN Stock MarketDetailed Quotes

688076 Jiangsu Sinopep-Allsino Biopharmaceutical

Watchlist
  • 69.34
  • -0.06-0.09%
Market Closed Jul 12 15:00 CST
15.13BMarket Cap72.68P/E (TTM)

Jiangsu Sinopep-Allsino Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Sinopep-Allsino Biopharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 23, 2024

Revenue(YoY)

355.82M

+71.02%
EPS(YoY)

0.30

+200.00%
Analyst Rating

Strong Buy

Jul 14, 2024

Jiangsu Sinopep-Allsino Biopharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.154B--
--2024/FY-- / 1.546B--
Mar 29, 20242023/FY1.036B / 950.510M--
--2022/FY651.292M / 659.000M--
--2021/FY643.869M / 642.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.154B--
--2024/FY-- / 1.546B--
Mar 29, 20242023/FY1.036B / 950.510M--
--2022/FY651.292M / 659.000M--
--2021/FY643.869M / 642.000M--

Unlock Free Earnings Estimates

Jiangsu Sinopep-Allsino Biopharmaceutical Earnings Reports

  • Jiangsu Sinopep-Allsino Biopharmaceutical: Voluntary disclosure announcement of the 2024 semi-annual performance forecast.

    Jun 19 12:00 ET

  • Nootech: Report for the first quarter of 2024

    Apr 22 12:00 ET

  • Nootech: Voluntary Disclosure Notice for the First Quarter of 2024 Earnings Forecast

    Apr 3 12:00 ET

  • Nootech: 2023 Annual Report Summary

    Mar 28 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 14, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg